CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.

Shi S, Zhou J, Luo Q, Chen H, Yang J, Yang L, Zhang L, Zhang H, Yang D

DOI: 10.1007/s11684-025-1166-y
Published: 2025 Dec 8
Container: Frontiers of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11684-025-1166-y,
  title = {CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.},
  author = {Shi S and Zhou J and Luo Q and Chen H and Yang J and Yang L and Zhang L and Zhang H and Yang D},
  year = {2025},
  journal = {Frontiers of medicine},
  doi = {10.1007/s11684-025-1166-y},
  url = {https://doi.org/10.1007/s11684-025-1166-y}
}

RIS

TY  - JOUR
TI  - CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.
AU  - Shi S
AU  - Zhou J
AU  - Luo Q
AU  - Chen H
AU  - Yang J
AU  - Yang L
AU  - Zhang L
AU  - Zhang H
AU  - Yang D
PY  - 2025
JO  - Frontiers of medicine
DO  - 10.1007/s11684-025-1166-y
UR  - https://doi.org/10.1007/s11684-025-1166-y
ER  -

APA

S, S., J, Z., Q, L., H, C., J, Y., L, Y., L, Z., H, Z., & D, Y. (2025). CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.. Frontiers of medicine. https://doi.org/10.1007/s11684-025-1166-y

Source records

pubmed · retrieved 2026-09-25T06:35:59.318Z